DiaCarta, Inc., a privately-held biotechnology company raised $8 million in Series A financing from BVCF (BioVeda China Fund). Proceeds from Series A financing will be used to expand the product portfolio and support global commercialization. Dr. Weixin Xu of BVCF will join DiaCarta board of directors.
from The Medical News http://ift.tt/1xP1oHY
from The Medical News http://ift.tt/1xP1oHY
No comments:
Post a Comment